購(gòu)物車(chē)
幫助
021-54845833/15800441009
中文名稱(chēng)： CD22抗原（重組蛋白）
英文名稱(chēng)： CD22 Antigen (Recombinant Protein)
別 名： SIGLEC2; SIGLEC-2
儲(chǔ) 存： 冷凍（-20℃）
相關(guān)類(lèi)別： 抗原
概 述：
|
Fusion protein corresponding to a region derived from C terminal 250 amino acids of human CD22 |
技術(shù)規(guī)格：
|
Full name: |
CD22 molecule |
|
Synonyms: |
SIGLEC2; SIGLEC-2 |
|
Swissprot: |
P20273 |
|
Gene Accession: |
BC109306 |
|
Purity: |
>85%, as determined by Coomassie blue stained SDS-PAGE |
|
Expression system: |
Escherichia coli |
|
Tags: |
His tag C-Terminus, GST tag N-Terminus |
|
Background: |
The B lymphocyte specific CD22 antigen, also designated B-lymphocyte cell adhesion molecule (BLCAM), sialic acid-binding Ig-like lectin 2 (Siglec-2) and Leu-14, is a type I integral membrane glycoprotein, structurally similar to other cell adhesion molecules (CAMs), which acts as a regulator of B cell signaling. CD22 is expressed as both a cytoplasmic and membrane protein during discrete stages of B cell lymphocyte differentiation. The cytoplasmic form of CD22, expressed early in B cell development, is a useful marker for acute lymphocytic leukemia. The membrane form of CD22 is expressed in mature B cells prior to their differentiation into plasma cells. |
